About swedencare - SWDCF
Swedencare AB is focuses on developing, manufactures, and sells premium products for the global and rapidly growing animal health market, with a focus on cats, dogs, and horses. Its products portfolio includes brands such as NaturVet, Innovet, Pet MD, Rx Vitamins, nutravet, Rileys, and ProDen PlaqueOff, the original product for good oral health. It operates through the following segments: North America, European, Production. The North America segment manages sales in the US and Canada. The European segment deals with the sales in Greece, Spain, Italy, France, Sweden, and the UK. The Production segment consists of production companies in the US, Canada, Ireland, and the UK. The company was founded by Sune Wikner and Roland Fastberg on June 30, 1993 and is headquartered in Malmo, Sweden.
SWDCF At a Glance
Swedencare AB
Medeon Science Park
Malmö, Skane 205 12
| Phone | 46-40-859-33 | | Revenue | 273.58M |
| Industry | Pharmaceuticals: Major | | Net Income | 5.66M |
| Sector | Health Technology | | 2025 Sales Growth | 14.317% |
| Fiscal Year-end | 12 / 2026 | | Employees | 613 |
|
View SEC Filings
| | | | |
SWDCF Valuation
| P/E Current | 94.562 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 117.335 |
| Price to Sales Ratio | 2.43 |
| Price to Book Ratio | 0.921 |
| Price to Cash Flow Ratio | 19.95 |
| Enterprise Value to EBITDA | 18.416 |
| Enterprise Value to Sales | 3.105 |
| Total Debt to Enterprise Value | 0.23 |
SWDCF Efficiency
| Revenue/Employee | 446,290.532 |
| Income Per Employee | 9,231.532 |
| Receivables Turnover | 5.32 |
| Total Asset Turnover | 0.278 |
SWDCF Liquidity
| Current Ratio | 2.639 |
| Quick Ratio | 1.46 |
| Cash Ratio | 0.246 |
SWDCF Profitability
| Gross Margin | 5.277 |
| Operating Margin | 5.277 |
| Pretax Margin | 3.034 |
| Net Margin | 2.069 |
| Return on Assets | 0.576 |
| Return on Equity | 0.781 |
| Return on Total Capital | 0.616 |
| Return on Invested Capital | 0.64 |
SWDCF Capital Structure
| Total Debt to Total Equity | 27.068 |
| Total Debt to Total Capital | 21.302 |
| Total Debt to Total Assets | 18.972 |
| Long-Term Debt to Equity | 26.279 |
| Long-Term Debt to Total Capital | 20.681 |